title: Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
abstract: OBJECTIVE
  To retrospectively compare fluorine 18 ((18)F) fluoro-L-dopa positron emission tomography (PET) and pancreatic venous sampling (PVS) in the preoperative differentiation of diffuse from focal congenital hyperinsulinism (CHI) and localization of focal lesions.
  
  
  METHODS
  This study was approved by the institutional ethical committee, and informed consent for the research study was obtained from the parents of all subjects. Fifty-one patients evaluated for focal CHI between January 1, 1995, and January 31, 2008, were included. Thirty five underwent PVS evaluation alone, and 16 underwent a PET evaluation alone. The sensitivity values of each technique for the diagnosis and localization of focal lesions were compared in regard to results of surgery and pathologic analyses. In each patient, perioperative treatment was reviewed, and the presence of postoperative hypoglycemia was assessed as evidence of incomplete resection. Comparisons of the sensitivity values and recurrence rates were performed by using the Fisher exact test in regard to the number of patients. Comparisons of median age, weight, or number of biopsies were performed with a two-tailed unpaired Mann-Whitney U test. A difference with P < .05 was considered significant.
  
  
  RESULTS
  For PVS and PET groups, there was no error in differentiating focal from diffuse forms. PVS was not completed in four of 35 patients. In 27 (87%) of 31 patients in whom PVS was completed and 13 (81%) of 16 patients in whom PET was completed, preoperative localization of the focal lesion was in accordance with the surgical findings (P = .7). Although not significant, the number of biopsies performed before discovering the focal lesion was higher in the PET group compared with the PVS group (P = .06). Inadequate localization occurred in two (6%) patients in the PVS group and five (31%) patients in the PET group at initial preoperative imaging study; these patients underwent repeat surgery for residual CHI (P = .03).
  
  
  CONCLUSIONS
  (18)F-fluoro-L-dopa PET is equivalent to PVS in the characterization of CHI but does not provide localization of the lesion as precisely as does PVS.
authors.affiliation: Departments of Pediatric Surgery, Radiology, Pathology, and Pediatrics, Necker-Enfants Malades Hospital, AP-HP, 75015 Paris, France. carmendoc@hotmail.com
authors.forename: Carmen
authors.initials: C
authors.lastname: Capito
authors.forename: Naziha
authors.initials: N
authors.lastname: Khen-Dunlop
authors.forename: Maria-João
authors.initials: MJ
authors.lastname: Ribeiro
authors.forename: Francis
authors.initials: F
authors.lastname: Brunelle
authors.forename: Yves
authors.initials: Y
authors.lastname: Aigrain
authors.forename: Célia
authors.initials: C
authors.lastname: Crétolle
authors.forename: Francis
authors.initials: F
authors.lastname: Jaubert
authors.forename: Pascale
authors.initials: P
authors.lastname: De Lonlay
authors.forename: Claire
authors.initials: C
authors.lastname: Nihoul-Fékété
mesh_terms: D044903:Congenital Hyperinsulinism / Q000000981:diagnostic imaging*; D003951:Diagnostic Errors; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012008:Recurrence; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric
chemical_list: D019275:Radiopharmaceuticals; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine